Curis develops Erivedge, a capsule manufactured for the treatment of adults with skin cancer. read more
Mark W. Noel ā Vice President of Technology Management & Intellectual Property at Curis
Executive Bio
Mr. Mark W. Noel has been Vice President of Technology Management & Intellectual Property at Curis, Inc. since September 2008. Mr. Noel served as Vice President of Technology Management & Business Development of Curis Inc. from March 2001 to September 2008. From March 2000 to February 2001 , Mr. Noel served as Vice President of Customer Relations of GeneLogic. From January1998 to February 2000, he served as Senior Director of Program Management of GeneLogic. From December 1993 to January 1998 , Mr. Noel was employed by the National Cancer Institute's Office of Technology Development (now the NCI Technology Transfer Center), where he served as Acting Deputy Director from July 1997 to January 1998. From February 1989 to November 1993, Mr. Noel served as a patent agent at Gist Brocades NV. Mr. Noel holds a B.S. from the University of Maryland.
Executive Team Culture Ratings from Curis Employees
BOTTOM
20%
Curis' Executive Team scores in the Bottom 20%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at CurisNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at CurisCuris' Executive Team at a Glance
Based on 3 ratings, Curis' employees are less satisfied with their Executive Team and give them a āDā or 60/100.
Curis' Executive Team ranks in the Bottom 25% of other companies in Boston and Bottom 20% of other companies on Comparably that also have 11-50 Employees.
×